What You Should Know:
– Arcadia, a healthcare data platform, announced a new AI-driven precision medicine solution designed to identify patients with undiagnosed or misdiagnosed conditions who are at risk of poor health outcomes.
– The…
Continue Reading
Palo Alto, Calif.-based Atropos Health, a company translating real-world clinical data into real-world evidence for decision-making, announced it is partnering with Merck to generate RWE, replicate studies, and produce rapid insights and analytics on…
Continue Reading
What You Should Know:
– Atropos Health, a pioneer in real-world evidence (RWE) generation, announced a collaboration with Merck to leverage its innovative platform for rapid insights and analytics from real-world data (RWD).
– The strategic…
Continue Reading
Real-world data is invaluable to healthcare tech developers. This type of data reflects actual patient experiences, treatments and outcomes in diverse, real-world environments — rather than controlled clinical trial settings, pointed out Atropos Health…
Continue Reading
What You Should Know:
– Scipher Medicine, a leader in precision medicine for autoimmune diseases, and Atropos Health, the pioneer in translating real-world clinical data into personalized real-world evidence, today announced a strategic partnership to accelerate…
Continue Reading
What You Should Know:
– Atropos Health, a leader in translating clinical data into high-quality, personalized, real-world evidence (RWE) for care, today announced the availability of AI model training on the Atropos Evidence Network, the…
Continue Reading
Mayo Clinic clinicians are starting to explore how they might use healthcare-specific large language models – accessed through a generative artificial intelligence chat application – to enhance patient care and improve clinical decisions.Where ChatGPT…
Continue Reading
The perspective on seeking investment varies company by company. Still, a common theme exists that it is necessary to ensure knowledge of the market and the actual value of one’s technology and that the…
Continue Reading
California-based real-world data platform Atropos Health has secured $33 million in Series B funding.Valtruis led the investment round, which included new investors McKesson Ventures, Merck GHI Fund and Cencora Ventures.
Existing investors Emerson Collective, Breyer…
What You Should Know:
– Atropos Health, the pioneer in translating real-world clinical data into high-quality personalized real-world evidence for care, today announced a $33 million Series B on the heels of the adoption of…
Continue Reading
